個人簡介：
中山大學(xué)附屬第七醫(yī)院研究員,，中山大學(xué)附屬第七醫(yī)院流行病與統(tǒng)計學(xué)教研室主任,，中山大學(xué)附屬第七醫(yī)院臨床研究中心副主任,，中山大學(xué)附屬第七醫(yī)院臨床醫(yī)學(xué)大數(shù)據(jù)中心副主任，伯明翰大學(xué)中山七院聯(lián)合臨床研究所副所長,，廣東省消化道惡性腫瘤防治工程技術(shù)中心副主任,。中山大學(xué)“百人計劃-青年學(xué)術(shù)骨干”海外高層引進(jìn)人才，深圳市海外高層次海外留學(xué)人才(孔雀計劃),，伯明翰大學(xué)Vanguard學(xué)者,，廣東省預(yù)防醫(yī)學(xué)會流行病學(xué)專委會青年委員會常委，中國控?zé)焻f(xié)會理事,；主要從事胃酸分泌減少的健康影響及生物醫(yī)學(xué)大數(shù)據(jù)相關(guān)研究,。累積發(fā)表SCI論文153篇，其中以第一作者/通訊作者累積在Gastroenterology,、Gut,、Nature communications、Eur Urol,、等雜志發(fā)表論文55篇,，累積引用次數(shù)>4300次, H-index = 38；執(zhí)筆3部國家指南《中國消化外科抑酸藥物規(guī)范化使用的臨床實(shí)踐指南（2022版）》,、《中國人群胃癌風(fēng)險管理公眾指南（2023版）》,、《中國人群骨質(zhì)疏松風(fēng)險管理公眾指南（2024版）》；主持國自然青年/面上項目,、Wellcome Leap臨床基金子項目等多項基金,；任Therapeutic Advances in Medical Oncology統(tǒng)計編輯。
?
教育背景：
1. 2018.01–2019.01 博士后, 香港中文大學(xué), 公共衛(wèi)生及基層醫(yī)療學(xué)院流行病學(xué)系
2. 2013.09–2017.11 香港中文大學(xué),，公共衛(wèi)生及基層醫(yī)療學(xué)院流行病學(xué)系,，流行病學(xué)博士
3. 2015.09–2016.01 布里斯托大學(xué)，社會和社區(qū)醫(yī)學(xué)學(xué)院統(tǒng)計學(xué)系,，訪問博士
4. 2011.09–2012.08?香港中文大學(xué),，公共衛(wèi)生及基層醫(yī)療學(xué)院流行病學(xué)系，公共衛(wèi)生碩士
5. 2006.09–2011.06?蘭州大學(xué),，第一臨床醫(yī)學(xué)院,，臨床醫(yī)學(xué)學(xué)士
?
研究工作經(jīng)歷：
1. 2025.1?- 至今: 研究員，中山大學(xué)附屬第七醫(yī)院,，科研中心
2. 2019.2 - 2024.12: 副研究員,，中山大學(xué)附屬第七醫(yī)院，科研中心
3. 2012.10 - 2013.08: 研究助理,，香港中文大學(xué),，公共衛(wèi)生及基層醫(yī)療學(xué)院流行病學(xué)系
?
研究方向：
1. 胃酸分泌減少的健康影響
2. 生物醫(yī)學(xué)大數(shù)據(jù)
3. 循證醫(yī)療決策
?
代表性論文：
1. Xia B, He Q, Smith FG, Gkoutos VG, Nirantharakumar K, Kuo ZC, Wang D, Feng Q, Cheung EC, Dai L, Huang J, Yu Y, Meng W*, Qin X*,?Yuan J*. Individualized prevention of proton pump inhibitor related adverse events by risk stratification. Nat Commun. 2024 Apr 27;15(1):3591.?(IF: 14.1)
2. Li W, Zhou Y, Luo Z, Tang R, Sun Y, He Q, Xia B, Lu K, Hou Q, Yuan J*. Lipidomic markers for the prediction of progression from mild cognitive impairment to Alzheimer's disease. FASEB J. 2023 Jul;37(7):e22998. (IF: 5.843)?
3. Zhang X, Yue P, Zhang J, Yang M, Chen J, Zhang B, Luo W, Wang M, Da Z, Lin Y, Zhou W, Zhang L, Zhu K, Ren Y, Yang L, Li S*, Yuan J*, Meng W*, Leung JW, Li X. A novel machine learning model and a public online prediction platform for prediction of post-ERCP-cholecystitis (PEC). EClinicalMedicine. 2022 May 13;48:101431.. (IF: 17.033)
4. Yang M, He Q, Gao F, Nirantharakumar K, Veenith T, Qin X, Page AT, Wong MCS, Huang J, Kuo ZC, Xia B, Zhang C, He Y, Meng W*, Yuan J*, Pan Y*. Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials. BMC Med. 2021 Dec 3;19(1):316.?(IF: 11.15)
5. Xia B, Yang M, Nguyen LH, He Q, Zhen J, Yu Y, Di M, Qin X, Lu K, Kuo ZC, He Y, Zhang C, Meng W,?Yuan J*. Regular Use of Proton Pump Inhibitor and the Risk of Inflammatory Bowel Disease: Pooled Analysis of 3 Prospective Cohorts. Gastroenterology. 2021 Dec;161(6):1842-1852?(IF: 33.883)
6. He Q, Xia B, Meng W, Fan D, Kuo ZC, Huang J, Qin X, Zou H, He Y, Zhang C, Fang S, Pan Y, Yang M,?Yuan J*. No Associations Between Regular Use of Proton Pump Inhibitors and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort of 0.44 Million Participants. Am J Gastroenterol. 2021 Nov 1;116(11):2286-2291. (IF:12.045)
7. Jinqiu Yuan, Qiangsheng He, Long H Nguyen, et al. Regular use of proton pump inhibitor and risk of type 2 diabetes: results from three prospective cohort studies. Gut. 2021 Jun;70(6):1070-1077. (IF:?31.793)
8. Qiangsheng He, Man Yang, Xiwen Qin, Die Fan, Jinqiu Yuan*, Yihang Pan*. Risk stratification for proton pump inhibitor-associated type 2 diabetes: a population-based cohort study. Gut. 2021 Nov;70(11):2212-2213?(IF:?31.793)
9. Jinqiu Yuan, Yanhong Jessika Hu, Jie Zheng, et al. Long-term use of antibiotics and risk of type 2 diabetes in women: a prospective cohort study. Int J Epidemiol. 2020 Oct 1;49(5):1572-1581. doi: 10.1093/ije/dyaa122.（IF: 9.685）
10. Jinqiu Yuan, Changhua Zhang,?Jeffrey A, et al. Regular use of proton pump inhibitor and risk of rheumatoid arthritis in women: a prospective cohort study. Aliment Pharmacol Ther 2020;52: 449-458.（IF=9.524）
11. Bin Xia, Qiang-Sheng He, Fang Gao, An-Ran Liu, Yan Tang, Charing Chong, Anthony Y. B. Teoh, Fang-Ping Li, Yi-Hang Pan, Yu-Long He*, Chang-Hua Zhang*, Jin-Qiu Yuan*. Metabolic Syndrome and Risk of Pancreatic Cancer: A population-based prospective cohort study. Int J Cancer. 2020 Dec 15;147(12):3384-3393（IF: 7.316）
12. Yuan JQ, Tsoi KK, Yang M, Wang JY, Threapleton DE, Yang ZY, Zou B, Mao C, Tang JL, Chan FK. Systematic review with network meta-analysis: comparative effectiveness and safety of strategies for preventing NSAID-associated gastrointestinal toxicity. Aliment Pharmacol Ther 2016;43(12): 1262-75（IF=9.524）
13. Wang H, Yuan J, Zhang B, Dong M, Mao C, Hu D. Phototherapy for treating foot ulcers in people with diabetes. Cochrane Database of Systematic Reviews 2015; 11: No.: CD011979?(IF: 6.103)
14. Yuan JQ, Zhang R, Yang Z, Lee J, Liu Y, Tian J, Qin X, Ren Z, Ding H, Chen Q, Mao C, Tang J. Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis. Eur Urol 2013; 63(5): 902-12. (IF: 24.267)
15.? Yuan JQ,?Mao C, Tang JL. Prevalence of risk factors for non-communicable diseases in prison populations. Lancet 2012; 380(9849): 1227. (IF: 44.002)?
??
聯(lián)系方式：
課題組長期招收流行病統(tǒng)計學(xué),、生物信息學(xué)、大數(shù)據(jù)人工智能相關(guān)助理/實(shí)習(xí)研究員及博士后,，有申請意愿歡迎郵件聯(lián)系（[email protected]）